These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34627422)
1. [Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia]. Zhou YL; Xu ZJ; Zhou JD; Zhang TJ; Yao DM; Ma JC; Lin J; Qian J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1436-1449. PubMed ID: 34627422 [TBL] [Abstract][Full Text] [Related]
2. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients]. Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374 [No Abstract] [Full Text] [Related]
3. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia. Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032 [TBL] [Abstract][Full Text] [Related]
4. Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia. Nan FY; Gu Y; Xu ZJ; Sun GK; Zhou JD; Zhang TJ; Ma JC; Leng JY; Lin J; Qian J Cancer Med; 2021 Aug; 10(15):5283-5296. PubMed ID: 34227248 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia. Wang CZ; Ma BB; Xu ZJ; Zhou JD; Zhang TJ; Chen Q; Yao DM; Lin J; Qian J; Sha S Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506368 [TBL] [Abstract][Full Text] [Related]
6. lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia. Sheng H; Zhang J; Ma Y; Zhang Y; Dai Y; Jiang R J Gene Med; 2021 Mar; 23(3):e3317. PubMed ID: 33474753 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens. Luo W; Yu H; Zou X; Ni X; Wei J Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595 [TBL] [Abstract][Full Text] [Related]
9. LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A. Zhou W; Xu S; Deng T; Zhou R; Wang C Hum Cell; 2022 Jan; 35(1):360-378. PubMed ID: 34694569 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis. Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245 [TBL] [Abstract][Full Text] [Related]
11. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis. Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia. Hola MAM; Ali MAM; ElNahass Y; Salem TAE; Mohamed MR Int J Lab Hematol; 2021 Aug; 43(4):732-742. PubMed ID: 34129278 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic Long Noncoding RNA DARS-AS1 in Childhood Acute Myeloid Leukemia by Binding to microRNA-425. Dou B; Jiang Z; Chen X; Wang C; Wu J; An J; Sheng G Technol Cancer Res Treat; 2020; 19():1533033820965580. PubMed ID: 33073700 [TBL] [Abstract][Full Text] [Related]
14. [Research Progress on Role of Long Non-Coding RNA in Occurrence and Development of Acute Myeloid Leukemia--Review]. Lu XS; Wang XQ; DU YN; Zhang JH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):974-978. PubMed ID: 38926999 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of ZEB2-AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia. Shi X; Li J; Ma L; Wen L; Wang Q; Yao H; Ruan C; Wu D; Zhang X; Chen S Oncol Lett; 2019 Jun; 17(6):4935-4947. PubMed ID: 31186703 [TBL] [Abstract][Full Text] [Related]
16. LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2. Liu M; Gou L; Xia J; Wan Q; Jiang Y; Sun S; Tang M; He T; Zhang Y Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941860 [TBL] [Abstract][Full Text] [Related]
17. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia. Jiang Z; Yu Q; Luo X J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217 [TBL] [Abstract][Full Text] [Related]
18. lncRNA TP73-AS1 Regulates miR-21/PTEN Axis to Affect Cell Proliferation in Acute Myeloid Leukemia. Yuan Z; Li L; Zheng M; Xu J; Wang W Cancer Biother Radiopharm; 2021 Apr; 36(3):268-272. PubMed ID: 32412786 [No Abstract] [Full Text] [Related]
19. Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia. Wei J; Huang XJ; Huang Y; Xiong MY; Yao XY; Huang ZN; Li SN; Zhou WJ; Fang DL; Deng DH; Cheng P Ann Transl Med; 2021 Sep; 9(17):1386. PubMed ID: 34733938 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia. Tian YJ; Wang YH; Xiao AJ; Li PL; Guo J; Wang TJ; Zhao DJ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1730-1737. PubMed ID: 31062614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]